Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maurizio Bifulco

Showing results (51-60 of 210) with videos related to

Pageof 21
Sort By:
The Lancet. Diabetes & Endocrinology|October 25, 2025
Obesity legally recognised as a chronic disease in ItalyMaurizio Bifulco, Cristina Pagano, Erika Di Zazzo
Neuropsychiatric Disease and Treatment|February 3, 2009
Cannabinoids in the management of spasticity associated with multiple sclerosisAnna Maria Malfitano, Maria Chiara Proto, Maurizio Bifulco
Proceedings of the National Academy of Sciences of the United States of America|February 14, 2002
2',3'-Cyclic nucleotide 3'-phosphodiesterase: a membrane-bound, microtubule-associated protein and membrane anchor for tubulinMaurizio Bifulco, Chiara Laezza, Stefania Stingo, et al.
The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|May 14, 2013
A focus on Trotula dé Ruggiero: a pioneer in women's and children's health in history of medicineMaurizio Bifulco, Elena Ciaglia, Magda Marasco, et al.
Addiction Biology|May 28, 2019
Novel role for cannabidiol in circadian clock functionMaurizio Bifulco, Giovanna Navarra, Chiara Laezza, et al.
British Journal of Pharmacology|February 28, 2006
Cannabinoids and cancer: pros and cons of an antitumour strategyMaurizio Bifulco, Chiara Laezza, Simona Pisanti, et al.
Nature Reviews. Drug Discovery|September 2, 2004
The endocannabinoid system and its therapeutic exploitationVincenzo Di Marzo, Maurizio Bifulco, Luciano De Petrocellis
Investigational New Drugs|February 4, 2009
A metabolically stable analogue of anandamide, Met-F-AEA, inhibits human thyroid carcinoma cell lines by activation of apoptosisRosanna Cozzolino, Gaetano Calì, Maurizio Bifulco, et al.
FEBS Letters|October 24, 2006
Anandamide inhibits Cdk2 and activates Chk1 leading to cell cycle arrest in human breast cancer cellsChiara Laezza, Simona Pisanti, Elvira Crescenzi, et al.
Thyroid : Official Journal of the American Thyroid Association|June 29, 2013
Concomitant BRAF(V600E) mutation and RET/PTC rearrangement is a frequent occurrence in papillary thyroid carcinomaAnna Guerra, Pio Zeppa, Maurizio Bifulco, et al.
Pageof 21

Showing results (51-60 of 210) with videos related to

Sort By:
Pageof 21
The Lancet. Diabetes & Endocrinology|October 25, 2025
Obesity legally recognised as a chronic disease in ItalyMaurizio Bifulco, Cristina Pagano, Erika Di Zazzo
Neuropsychiatric Disease and Treatment|February 3, 2009
Cannabinoids in the management of spasticity associated with multiple sclerosisAnna Maria Malfitano, Maria Chiara Proto, Maurizio Bifulco
Proceedings of the National Academy of Sciences of the United States of America|February 14, 2002
2',3'-Cyclic nucleotide 3'-phosphodiesterase: a membrane-bound, microtubule-associated protein and membrane anchor for tubulinMaurizio Bifulco, Chiara Laezza, Stefania Stingo, et al.
The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|May 14, 2013
A focus on Trotula dé Ruggiero: a pioneer in women's and children's health in history of medicineMaurizio Bifulco, Elena Ciaglia, Magda Marasco, et al.
Addiction Biology|May 28, 2019
Novel role for cannabidiol in circadian clock functionMaurizio Bifulco, Giovanna Navarra, Chiara Laezza, et al.
British Journal of Pharmacology|February 28, 2006
Cannabinoids and cancer: pros and cons of an antitumour strategyMaurizio Bifulco, Chiara Laezza, Simona Pisanti, et al.
Nature Reviews. Drug Discovery|September 2, 2004
The endocannabinoid system and its therapeutic exploitationVincenzo Di Marzo, Maurizio Bifulco, Luciano De Petrocellis
Investigational New Drugs|February 4, 2009
A metabolically stable analogue of anandamide, Met-F-AEA, inhibits human thyroid carcinoma cell lines by activation of apoptosisRosanna Cozzolino, Gaetano Calì, Maurizio Bifulco, et al.
FEBS Letters|October 24, 2006
Anandamide inhibits Cdk2 and activates Chk1 leading to cell cycle arrest in human breast cancer cellsChiara Laezza, Simona Pisanti, Elvira Crescenzi, et al.
Thyroid : Official Journal of the American Thyroid Association|June 29, 2013
Concomitant BRAF(V600E) mutation and RET/PTC rearrangement is a frequent occurrence in papillary thyroid carcinomaAnna Guerra, Pio Zeppa, Maurizio Bifulco, et al.
Pageof 21